

MOD GFR 1-29 5 MG INJECTION
Drug Class: Growth Hormone-Releasing Hormone (GHRH) Analog
Composition:
- Active Substance: Mod GFR 1-29
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Form: Lyophilized Powder
Manufacturer: Peptide Hubs
Tested in Laboratory: View Lab Report
Peptide Hubs presents pharmaceutical-grade CJC-1295 No DAC (Mod GRF 1-29), a potent growth hormone-releasing hormone analog specifically engineered for research purposes. Our 5mg vials contain pure lyophilized powder that stimulates natural pituitary secretion of growth hormone without the Drug Affinity Complex (DAC) found in other variants.
CJC-1295 No DAC works by binding to growth hormone-releasing hormone receptors in the pituitary gland, stimulating the natural pulsatile release of growth hormone. This mechanism differs from exogenous growth hormone administration as it maintains the body's natural rhythm and feedback systems. Research indicates this peptide may support increased lean muscle mass, enhanced fat metabolism, improved sleep quality, and accelerated recovery times. The absence of DAC means the compound has a shorter half-life, resulting in more physiological hormone pulses similar to the body's natural secretion patterns. Clinical studies on growth hormone secretagogues have demonstrated their potential in endocrine research applications.
For research purposes, typical CJC-1295 No DAC dosage ranges between 100-300mcg per administration. The peptide should be reconstituted with bacteriostatic water to ensure stability and purity. Most research protocols administer the compound 1-3 times daily to mimic natural growth hormone pulses. Due to its short half-life (approximately 30 minutes), timing of administration is crucial for optimal research outcomes. Researchers should consider administering doses during periods when natural growth hormone secretion is typically highest, such as during sleep or following exercise.
Research cycles for CJC-1295 No DAC typically span 8-12 weeks, followed by a 4-week break to prevent receptor desensitization. Many researchers combine this peptide with other complementary compounds for enhanced effects. Popular stacking options include GHRP-6 for increased hunger and growth hormone release, Ipamorelin for a more selective growth hormone secretagogue effect, Tesamorelin for targeted fat reduction research, BPC-157 for tissue repair studies, and TB-500 for comprehensive recovery research. These combinations allow for targeted investigation of specific physiological processes while maintaining the natural pulsatile release pattern of growth hormone.
While generally well-tolerated in research settings, some studies have reported transient side effects including flushing, dizziness, or tingling sensations at administration sites. These effects typically diminish with continued use. Unlike CJC-1295 with DAC, the No DAC version does not cause sustained elevated growth hormone levels, reducing the risk of side effects associated with chronic elevation such as carpal tunnel syndrome or insulin resistance. As with any research compound, proper laboratory protocols should be followed to ensure safety and accurate results.
Proper reconstitution is essential for maintaining peptide integrity. CJC-1295 No DAC should be reconstituted with bacteriostatic water and gently swirled until clear. Avoid vigorous shaking as this may damage the peptide structure. Reconstituted peptide should be refrigerated and used within 4-6 weeks. Unreconstituted vials remain stable for up to 24 months when stored in a cool, dark place away from moisture. For optimal results, researchers should follow strict sterile techniques during handling and administration.
Every batch of Peptide Hubs CJC-1295 No DAC undergoes rigorous third-party testing to verify purity, potency, and sterility. Our manufacturing process complies with strict quality control standards, ensuring researchers receive consistent, pharmaceutical-grade product. Learn more about CJC-1295 No DAC quality standards and our commitment to research excellence. Each vial contains precisely 5mg of pure peptide, accurately measured for precise dosing in research applications.
CJC-1295 with DAC includes a Drug Affinity Complex that binds to albumin, significantly extending its half-life to several days. This results in sustained elevation of growth hormone levels. CJC-1295 No DAC (Mod GRF 1-29) has a much shorter half-life (approximately 30 minutes), creating pulsatile releases that more closely mimic the body's natural growth hormone secretion pattern.
Reconstitute with 1-2mL of bacteriostatic water. Gently inject the water down the side of the vial to avoid aggressive agitation. Roll the vial gently between your hands until the powder is fully dissolved. Do not shake the vial vigorously as this can damage the peptide structure. Once reconstituted, store in the refrigerator and use within 4-6 weeks.
Most research protocols use 100-300mcg per administration, typically 1-3 times daily. The optimal dosage depends on the specific research objectives and model being studied. Many researchers start at the lower end of this range and adjust based on observed parameters. Administration is often timed to coincide with natural growth hormone peaks, such as before sleep or post-exercise.
Yes, researchers often stack CJC-1295 No DAC with other peptides for synergistic effects. Common combinations include GHRP-6, Ipamorelin, Tesamorelin, and other growth hormone secretagogues. These stacks can be tailored to specific research goals, whether focused on muscle growth, fat loss, or recovery processes. Always follow proper research protocols when combining compounds.
Unreconstituted vials should be stored in a cool, dark place away from moisture. For long-term storage, refrigeration is recommended. Reconstituted peptide must be refrigerated at 2-8°C (36-46°F) and used within 4-6 weeks. Avoid freezing reconstituted peptide as crystal formation may damage the molecular structure. Always protect the peptide from direct light and extreme temperature fluctuations.
Please log in to write CJC-1295 No DAC 5 mg review.
PENTADECAPEPTIDE 2 MG INJECTION
Drug Class: Healing/Repair Peptide
Composition:
- Active Substance: Pentadecapeptide
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Form: Lyophilized Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report